Centiva Capital
ACHN

Centiva Capital’s Achillion Pharmaceuticals ACHN Stock Holding History

Centiva Capital’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-75,000
Closed -$452K – 1037
2019
Q4 		$452K Buy
+75,000
New +$434K 0.02% 463

Centiva Capital's ACHN Position: Q1 2020 in Review

Centiva Capital sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 75,000 shares — an estimated $452K sold.

Centiva Capital first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $452K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Centiva Capital reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Centiva Capital sold 75,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $452K.
  • Centiva Capital first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Centiva Capital's Achillion Pharmaceuticals position peaked at $452K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Centiva Capital's 13F filing for Q1 2020, filed 15 May 2020.